FDA Import Refusal SCS-4626991-7/11/1 — Miralax Merck
The FDA refused shipment SCS-4626991-7/11/1 from Miralax Merck (United States) on May 15, 2019. The refused product falls under Drugs and Biologics — LOSARTAN POTASSIUM (ANTI-HYPERTENSIVE - PART II). Cited charge: 75
Refusal details
- Date
- May 15, 2019
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 62OCA41 LOSARTAN POTASSIUM (ANTI-HYPERTENSIVE - PART II)
- Charges
- 75